Coming soon from SECUADO

SECUADO®, the first and only FDA-approved transdermal system for adults with schizophrenia: IT’S ON

Why transdermal?

When your patients with schizophrenia are ready for a change of treatment, the transdermal patch offers you the opportunity to change the conversation with a different treatment option. The SECUADO® patch is an option for your patients who:

• Are looking for or need a different atypical antipsychotic treatment
• Want an alternative to swallowing pills or receiving injections
• Dislike food or drink restrictions when taking medicine
• Might be candidates for a once-daily treatment they can wear

Transdermal delivery is different

SECUADO® releases medication gradually, for consistent and sustained delivery over 24 hours.1,3 The transdermal route of administration avoids first-pass hepatic metabolism4-6 and has the potential to reduce GI tolerability concerns.4,5,7 Absorption is not impacted by the timing of food or drink.4,7

SECUADO® provided smooth onset, steady delivery, and low peak-to-trough ratios3

Asenapine pharmacokinetics at steady state is dose-proportional in the dose range of 3.8 mg/24 hours to 7.6 mg/24 hours following application of the patch.1 Steady-state plasma concentrations are achieved in about 72 hours after the first application of SECUADO.1Avoid exposing SECUADO® to direct external heat sources during wear because both the rate and extent of absorption are increased.

    You are now leaving the SECUADO® (asenapine) transdermal system website and moving to an external website independently operated and not managed by Noven

    COVID-19 response

    We are fully committed to supporting you and making sure your medication is accessible when you need it.

    The SECUADO® (asenapine) transdermal patch is available at this time with a prescription from your healthcare provider, as is our patient assistance program, the Noven Care Access Network (Noven C.A.N.™). To contact a Noven C.A.N. specialist, please call 888-526-0132.

    For additional information, please call 800-455-8070.

    See full Prescribing Information, including BOXED WARNING, here.

    SDO-2123-16   06/21
    For US audience only.

    The site you are about to enter is intended specifically for US healthcare professionals.

    Click continue if you are a US healthcare professional.